investigational new drug
Entity, reached from Hormuz.
- Evidence
- 54 documents · 14 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 12 Apr 2026, last seen 9 Oct 2026
- Measured
- 35% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- FDA · 2026-10-09 · Phase 1 Investigational New Drug (IND) Navigator (opens the source in a new tab)
- FDA · 2026-10-09 · Phase 1 IND Frequently Asked Questions (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-08 · Dignify Therapeutics secures FDA clearance for Phase I DTI-117 trial (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-05 · Surrozen secures FDA clearance for SZN-8141 clinical trial (opens the source in a new tab)
- FDA · 2026-09-22 · FDA Actions to Accelerate and Modernize Early and Late-Stage Clinical Development (opens the source in a new tab)
- FDA · 2026-09-17 · Investigational New Drug Application (IND) (opens the source in a new tab)
- FDA · 2026-09-16 · FDA Expedited Investigational New Drug (IND) Pilot Program (opens the source in a new tab)
- FDA Drug News · 2026-09-16 · Expedited Investigational New Drug Pilot Program - Application Instructions (opens the source in a new tab)
- FDA Drug News · 2026-06-18 · Investigational New Drug (IND) Application (opens the source in a new tab)
- FDA Drug News · 2026-06-10 · Final Rule: Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequ… (opens the source in a new tab)
2 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with fda (46 documents)seen together
- co-mentioned with drug administration (23 documents)seen together
- co-mentioned with clinical trial (22 documents)seen together
- co-mentioned with drug development (22 documents)seen together
- co-mentioned with clinical trials (19 documents)seen together
- co-mentioned with cder (16 documents)seen together
- co-mentioned with drug evaluation (16 documents)seen together
- co-mentioned with inds (15 documents)seen together
- co-mentioned with biological products (12 documents)seen together
- co-mentioned with cber (12 documents)seen together